ApoE genotype, past adult lead exposure, and neurobehavioral function.
暂无分享,去创建一个
David Simon | Brian S Schwartz | Walter F Stewart | W. Stewart | B. Schwartz | A. Todd | K. Kelsey | D. Simon | Andrew C Todd | Karl Kelsey
[1] A. Hume,et al. Developmental lead exposure alters the distribution of protein kinase C activity in the rat hippocampus. , 1998, Biomedical and environmental sciences : BES.
[2] Eric R. Ziegel,et al. Generalized Linear Models , 2002, Technometrics.
[3] L. Murray,et al. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[4] D. Graham,et al. beta A4 amyloid protein deposition in brain after head trauma. , 1991, Lancet.
[5] J. Rungby,et al. Dose-dependent bimodal effect of low-level lead exposure on the developing hippocampal region of the rat: a volumetric study. , 1989, Neurotoxicology.
[6] B. Gordon,et al. Past adult lead exposure is associated with longitudinal decline in cognitive function , 2000, Neurology.
[7] M. Weissman,et al. Assessing depressive symptoms in five psychiatric populations: a validation study. , 1977, American journal of epidemiology.
[8] B S Schwartz,et al. Characterization of toxicokinetics and toxicodynamics with linear systems theory: application to lead-associated cognitive decline. , 2001, Environmental health perspectives.
[9] P. Froom,et al. Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury , 1999, Neurology.
[10] T. Stone,et al. Nitric oxide synthase inhibitors l-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity , 1998, Neuroscience Letters.
[11] P. McCullagh,et al. Generalized Linear Models , 1992 .
[12] John F Rosen,et al. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects , 1998, Brain Research Reviews.
[13] R Attewell,et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. , 1993, Archives of environmental health.
[14] N. Zawia,et al. Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain. , 1996, Toxicology and applied pharmacology.
[15] A. Todd. Calculating bone-lead measurement variance. , 1999, Environmental health perspectives.
[16] O. Gureje,et al. Apolipoprotein E—associated risk for Alzheimer's disease in the African‐American population is genotype dependent , 1997, Annals of neurology.
[17] H. Offner,et al. THE EFFECT OF TRIETHYLLEAD ON TOTAL AND MYELIN PROTEIN SYNTHESIS IN RAT FOREBRAIN SLICES , 1979, Journal of neurochemistry.
[18] J Agnew,et al. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. , 1993, American journal of epidemiology.
[19] V. Miletić,et al. Prenatal and postnatal chronic exposure to low levels of inorganic lead attenuates long-term potentiation in the adult rat hippocampus in vivo , 1997, Neuroscience Letters.
[20] K. J. Murphy,et al. Influence of toxicants on neural cell adhesion molecule-mediated neuroplasticity in the developing and adult animal: persistent effects of chronic perinatal low-level lead exposure. , 1995, Toxicology letters.
[21] F. McNeill,et al. In vivo measurements of lead in bone using a 109Cd 'spot' source. , 1993, Basic life sciences.
[22] Triethyl and trimethyl lead: effects on behavior, CNS morphology and concentrations of lead in blood and brain of rat. , 1986, Neurotoxicology.
[23] Kala Sv,et al. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. , 1995 .
[24] E. Albuquerque,et al. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. , 1996, The Journal of pharmacology and experimental therapeutics.
[25] Tilson Ha,et al. Neurobehavioral toxicology of the organoleads. , 1984 .
[26] C. Stournaras,et al. The interaction of triethyl lead with tubulin and microtubules. , 1988, Mutation research.
[27] A. Todd,et al. In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. , 1992, Environmental research.
[28] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[29] B. Tycko,et al. Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.
[30] N. Relkin,et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.
[31] B. Tycko,et al. Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.
[32] D. Graham,et al. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.
[33] Chronic lead exposure induces astrogliosis in hippocampus and cerebellum. , 1994, Neurotoxicology.
[34] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[35] H. Wiegand,et al. Synaptic plasticity in the CA1 and CA3 hippocampal region of pre- and postnatally lead-exposed rats. , 1998, Toxicology letters.
[36] T. J. Walsh,et al. Neurobehavioral toxicology of the organoleads. , 1984, Neurotoxicology.
[37] A. R. Little,et al. Trimethyl lead neurotoxicity in the rat: changes in glial fibrillary acidic protein (GFAP). , 1995, Arhiv za higijenu rada i toksikologiju.
[38] Triethyllead and cerebral development: an overview. , 1984, Neurotoxicology.
[39] D Simon,et al. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers , 1999, Neurology.
[40] A. L. Jadhav,et al. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. , 1995, Neurotoxicology.
[41] W. Niklowitz,et al. Neurofibrillary changes after acute experimental lead poisoning , 1975, Neurology.
[42] A. Hofman,et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.
[43] Howard Hu,et al. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.
[44] S. Sorbi,et al. ApoE as a prognostic factor for post–traumatic coma , 1995, Nature Medicine.
[45] S. Daya,et al. Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus , 1998, Journal of Chemical Neuroanatomy.
[46] Y. Xu,et al. Nitric oxide affects LTP in area CA1 and CA3 of hippocampus in low-level lead-exposed rat. , 1998, Neurotoxicology and teratology.